UnitedHealth Group Incorporated (UNH) Price Target Raised to $235.00 at Citigroup Inc.

UnitedHealth Group Incorporated (NYSE:UNH) had its target price increased by Citigroup Inc. from $213.00 to $235.00 in a report released on Wednesday. Citigroup Inc. currently has a buy rating on the healthcare conglomerate’s stock.

UNH has been the topic of several other reports. UBS AG restated an overweight rating on shares of UnitedHealth Group in a research note on Thursday, August 24th. BidaskClub upgraded UnitedHealth Group from a buy rating to a strong-buy rating in a research note on Saturday, July 8th. Morgan Stanley upped their price objective on UnitedHealth Group from $202.00 to $210.00 and gave the company an overweight rating in a research note on Wednesday, June 28th. Bank of America Corporation upped their price objective on UnitedHealth Group from $210.00 to $214.00 and gave the company a buy rating in a research note on Friday, July 14th. Finally, Zacks Investment Research lowered UnitedHealth Group from a buy rating to a hold rating in a research note on Tuesday, September 26th. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. The stock presently has an average rating of Buy and an average target price of $215.27.

Shares of UnitedHealth Group (NYSE UNH) traded down 0.70% during midday trading on Wednesday, reaching $203.80. The company’s stock had a trading volume of 2,443,443 shares. The stock’s 50-day moving average is $196.96 and its 200 day moving average is $185.50. UnitedHealth Group has a 12 month low of $133.03 and a 12 month high of $207.80. The stock has a market capitalization of $201.56 billion, a P/E ratio of 23.14 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. During the same period in the previous year, the company posted $2.17 earnings per share. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. On average, analysts expect that UnitedHealth Group will post $9.91 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “UnitedHealth Group Incorporated (UNH) Price Target Raised to $235.00 at Citigroup Inc.” was originally published by Markets Daily and is the sole property of of Markets Daily. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.themarketsdaily.com/2017/10/19/unitedhealth-group-incorporated-unh-price-target-raised-to-235-00-at-citigroup-inc.html.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were issued a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.46%. The ex-dividend date was Thursday, September 7th. UnitedHealth Group’s dividend payout ratio is 33.26%.

In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of the company’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the transaction, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total value of $969,900.00. Following the transaction, the director now directly owns 76,058 shares in the company, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 76,174 shares of company stock worth $14,981,909. Company insiders own 0.89% of the company’s stock.

A number of large investors have recently bought and sold shares of UNH. Patriot Financial Group Insurance Agency LLC lifted its holdings in UnitedHealth Group by 1,722.9% during the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares in the last quarter. Blue Chip Partners Inc. acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $110,000. Kings Point Capital Management lifted its stake in shares of UnitedHealth Group by 27.9% in the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after purchasing an additional 150 shares during the period. Bruderman Asset Management LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $114,000. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its stake in shares of UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares during the period. 86.11% of the stock is currently owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply